Factorial invariance of the generalized anxiety disorder scale (GAD-7) in Latin America and the Caribbean

Introduction: The prevalence of Generalized Anxiety Disorder (GAD) has increased rapidly, highlighting the importance of its detection using quick tools applicable to men and women from different countries. Objective: To analyze the psychometric properties of the Generalized Anxiety Disorder Test (G...

Full description

Autores:
López Velásquez, Norman
Carlos Coronado, Juan
Ripoll Cordoba, Daniela
Caldichoury, Nicole
Quispe-Ayala, Cesar
Morales-Asencio, Breiner
Quincho Apumayta, Raul
Castellanos, Cesar
Martínez, Juan
Cardenas Valverde, Juan
Castellanos Alvarenga, Luis Mario
Salazar, David
Flores Poma, Irina
Herrera Pino, Jorge
Bada, Wendy
Florez, Yuliana
Alcos Flores, Karen
Zurita Cueva, Boris
Muñoz Romero, Elsa
Romo, Cristian
Antezana, Regulo
Avila Saldaña, Claudio
Gargiulo, Pascual A.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2025
Institución:
Corporación Universidad de la Costa
Repositorio:
REDICUC - Repositorio CUC
Idioma:
eng
OAI Identifier:
oai:repositorio.cuc.edu.co:11323/14161
Acceso en línea:
https://hdl.handle.net/11323/14161
https://repositorio.cuc.edu.co/
Palabra clave:
Generalized anxiety disorder
Psychometric indicators
Invariance
Test
Latin American population
Rights
openAccess
License
Atribución 4.0 Internacional (CC BY 4.0)
Description
Summary:Introduction: The prevalence of Generalized Anxiety Disorder (GAD) has increased rapidly, highlighting the importance of its detection using quick tools applicable to men and women from different countries. Objective: To analyze the psychometric properties of the Generalized Anxiety Disorder Test (GAD-7) by gender and country in Latin America and the Caribbean (LAC). Method: A cross-sectional e-health study with 12,124 participants from 15 LAC countries (54.32% women, 45.68% men) was conducted, including participants from Argentina (7.3%), Bolivia (6.7%), Colombia (10.3%), Chile (6.9%), Costa Rica (4.9%), El Salvador (5.7%), Ecuador (7.2%), Guatemala (4.7%), Panama (5.1%), Paraguay (5.7%), Peru (8.6%), Puerto Rico (5.8%), the Dominican Republic (6.6%), Uruguay (6.3%), and Venezuela (8.2%). All participants completed the GAD-7 scale digitally. Results: A unidimensional structure of the GAD-7 was confirmed, explaining 70% of the variance. The model fit indices were adequate (RMSEA = 0.062; CFI = 0.997; TLI = 0.995; SRMR = 0.017; p < 0.001), and the factor loadings for each item were satisfactory (> 0.70). Additionally, the factor structure showed measurement invariance between genders and countries, with adequate fit indices at all levels (configural, metric, scalar, and strict), suggesting that the measurements are equivalent in both contexts. Finally, the internal consistency of the GAD-7 was high, with a McDonald’s Omega coefficient of 0.91. Conclusions: The GAD-7 exhibits a factor structure that is equivalent across genders and countries, demonstrating its validity and reliability for the rapid detection of GAD symptoms in different countries within the region